Cardiprin (Aspirin) in Pregnancy: Risks, Indications & Dosing Guidance
Cardiprin is a brand of low-dose aspirin (typically 100 mg enteric-coated). Use in pregnancy is indication-specific—not routine.
Contraindicated / Avoid
- First trimester (organogenesis): Theoretical teratogenicity (gastroschisis, cardiac defects) – animal data; human studies inconsistent. Avoid unless benefit clearly outweighs risk.
- Third trimester (≥30 weeks): Risk of premature closure of fetal ductus arteriosus (→ pulmonary hypertension, right heart failure), platelet dysfunction (maternal/fetal bleeding), oligohydramnios (renal prostaglandin inhibition), prolonged gestation/labor.
- High-dose aspirin (>150 mg/day): Not indicated in pregnancy; greater risks.
Indicated Uses (Low-Dose Aspirin 75–150 mg/day)
| Indication | Timing | Evidence / Guideline |
|---|---|---|
| Preeclampsia prevention | Initiate 12–16 weeks (≤28 wks); continue until delivery or 36 wks | USPSTF Grade A, ACOG, SMFM – high risk (prev PE, multifetal, chronic HTN, diabetes, renal, autoimmune) or moderate risk ×2 |
| Antiphospholipid syndrome (APS) | Preconception or early pregnancy | Combined with prophylactic LMWH; specialist management |
| Recurrent pregnancy loss (APS-associated) | Preconception | Same as above |
| Fetal growth restriction prevention (selected) | Early 2nd trimester | Less established; individualized |
Dosing & Monitoring
- Dose: 81 mg (US) or 75–100 mg (international) enteric-coated daily at bedtime (better compliance, possibly better effect).
- Monitoring: BP, urine protein, uterine artery Doppler (if indicated), fetal growth scans, maternal platelet count/renal function if risk factors.
- Discontinuation: Typically 36–37 weeks for preeclampsia prevention (balance ductus risk vs. benefit); individualized for APS.
Patient Counseling Points
- Do not self-start aspirin in pregnancy. Requires provider prescription & risk assessment.
- Inform all providers (dentist, surgeons) – bleeding risk.
- Stop immediately if: vaginal bleeding, signs of placental abruption, impending delivery, allergic reaction.
- Not a substitute for prenatal care, BP control, or indicated antihypertensives (labetalol, nifedipine, methyldopa).
Key Society Guidelines
- ACOG Practice Bulletin 222 (2020) – Low-dose aspirin for preeclampsia prevention
- USPSTF Recommendation (2021) – Grade A for high-risk
- SMFM Consult Series #52 (2022)
- ISSHP (International Society for Study of Hypertension in Pregnancy)
This is general medical information. Obstetric management must be individualized by the treating clinician.
Pregnancy & Health - Related Articles
- Conception Date Calculator: Determining Conception from Due Date
- Protruding Belly Button (Non‑Pregnant): Causes & When to See a Doctor
- Common Causes of Infertility in Men and Women: A Complete Guide
- Fetal Heartbeat & Ultrasound: What to Expect at 11 Weeks
- Return of Menstruation After Childbirth: Timing, Breastfeeding Effects, and Variability
- When Do You Start Showing in Pregnancy? Timeline and Factors
- Best Books to Read to Your Baby in the Womb: 15 Beloved Classics
